Phase I study of HS-110 in non-small cell lung cancer.
Phase of Trial: Phase I
Latest Information Update: 26 Apr 2018
At a glance
- Drugs Viagenpumatucel-L (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 26 Apr 2018 New trial record
- 18 Apr 2018 According to the Heat Biologics media release, compnay plans to file IND and enroll first patient in this trial in Q4 2018 and anticipates an interim data readout in Q2 2019.